{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:38:07Z","timestamp":1791121087014,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T00:00:00Z","timestamp":1414627200000},"content-version":"vor","delay-in-days":363,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.euroneuro.2013.05.012","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T09:15:28Z","timestamp":1374225328000},"page":"1423-1431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder"],"prefix":"10.1016","volume":"23","author":[{"given":"Damiaan","family":"Denys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Froukje","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Cath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Figee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke","family":"Vulink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick J.","family":"Veltman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalia F.","family":"van der Doef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Boellaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Westenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"van Balkom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A.","family":"Lammertsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart N.M.","family":"van Berckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2013.05.012_bib1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.biopsych.2008.12.007","article-title":"Baseline and amphetamine-stimulated dopamine activity are related in drug-naive schizophrenic subjects","volume":"65","author":"Abi-Dargham","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.WNL.0000076181.39162.FC","article-title":"Increased ventral striatal monoaminergic innervation in Tourette syndrome","volume":"61","author":"Albin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib3","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1212\/WNL.0b013e3181a187dd","article-title":"Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome","volume":"72","author":"Albin","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-1781(90)90151-T","article-title":"Motor\/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability?","volume":"33","author":"Borcherding","year":"1990","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/npp.2008.138","article-title":"Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum","volume":"34","author":"Bossong","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00004647-199704000-00009","article-title":"Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion","volume":"17","author":"Carson","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00004583-199705000-00008","article-title":"Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose","volume":"5","author":"Castellanos","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/npp.2008.3","article-title":"Effect of menstrual cycle phase on dopamine D2 receptor availability in female cynomolgus monkeys","volume":"34","author":"Czoty","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.psc.2006.02.013","article-title":"Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders","volume":"29","author":"Denys","year":"2006","journal-title":"Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.biopsych.2004.01.023","article-title":"Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder","volume":"55","author":"Denys","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.psychres.2008.06.008","article-title":"Tourette's syndrome, trichotillomania, and obsessive-compulsive disorder: how closely are they related?","volume":"170","author":"Ferrao","year":"2009","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib12","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.neuroimage.2005.08.012","article-title":"A critique of functional localisers","volume":"30","author":"Friston","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0925-4927(94)90014-0","article-title":"Dopamine receptor availability in Tourette's syndrome","volume":"55","author":"George","year":"1994","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-3999(02)00581-0","article-title":"Developmental processes and brain imaging studies in Tourette syndrome","volume":"55","author":"Gerard","year":"2003","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib15","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1212\/01.wnl.0000242733.18534.2c","article-title":"Altered mesolimbocortical and thalamic dopamine in Tourette syndrome","volume":"67","author":"Gilbert","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib16","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0306-4522(83)90135-5","article-title":"Intracellular and extracellular electrophysiology of nigral dopaminergic neurons\u20141. Identification and characterization","volume":"10","author":"Grace","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tins.2007.03.003","article-title":"Regulation of firing of dopaminergic neurons and control of goal-directed behaviors","volume":"30","author":"Grace","year":"2007","journal-title":"Trends Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2013.05.012_bib19","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0387-7604(03)90001-5","article-title":"Does an imbalance between the dorsal and ventral striatopallidal systems play a role in Tourette's syndrome? A neuronal circuit approach","volume":"25","author":"Groenewegen","year":"2003","journal-title":"Brain Dev."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/nimg.1997.0303","article-title":"Parametric imaging of ligand-receptor binding in PET using a simplified reference region model","volume":"6","author":"Gunn","year":"1997","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib21","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00004647-199601000-00005","article-title":"Comparison of methods for analysis of clinical [11C]raclopride studies","volume":"16","author":"Lammertsma","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","article-title":"Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review","volume":"20","author":"Laruelle","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/da.20669","article-title":"Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V","volume":"27","author":"Leckman","year":"2010","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib25","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0006-3223(91)90141-8","article-title":"Hormonal response to fenfluramine challenges in clozapine-treated schizophrenic patients","volume":"29","author":"Lemus","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib27","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.1982.03320370043028","article-title":"Stimulant medications precipitate Tourette's syndrome","volume":"247","author":"Lowe","year":"1982","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nn.2723","article-title":"From reinforcement learning models to psychiatric and neurological disorders","volume":"14","author":"Maia","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.53.2.371","article-title":"Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome","volume":"53","author":"Meyer","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib30","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.biopsych.2006.01.008","article-title":"Sex differences in striatal dopamine release in healthy adults","volume":"59","author":"Munro","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0925-4927(98)00021-3","article-title":"A PET study of D2 dopamine receptor density at different phases of the menstrual cycle","volume":"83","author":"Nordstrom","year":"1998","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jad.2008.06.020","article-title":"Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder","volume":"114","author":"Olver","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neuroimage.2007.01.055","article-title":"Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release","volume":"36","author":"Oswald","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuroimage.2008.04.233","article-title":"In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder","volume":"42","author":"Perani","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archpsyc.58.5.427","article-title":"Regional brain and ventricular volumes in Tourette syndrome","volume":"58","author":"Peterson","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib36","first-page":"768","article-title":"Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo","volume":"155","author":"Pohjalainen","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"Pt 3","key":"10.1016\/j.euroneuro.2013.05.012_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/brain\/123.3.425","article-title":"Tourette syndrome, associated conditions and the complexities of treatment","volume":"123","author":"Robertson","year":"2000","journal-title":"Brain"},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2013.05.012_bib38","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0387-7604(03)90002-7","article-title":"Pathophysiology of Tourette's syndrome: striatal pathways revisited","volume":"25","author":"Saka","year":"2003","journal-title":"Brain Dev."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/da.20268","article-title":"Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings","volume":"25","author":"Schneier","year":"2008","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib40","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1176\/appi.ajp.159.8.1329","article-title":"Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET","volume":"159","author":"Singer","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib41","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archpsyc.1992.01820080032005","article-title":"The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description","volume":"49","author":"Spitzer","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib42","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/jnnp.57.6.688","article-title":"PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome","volume":"57","author":"Turjanski","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib43","first-page":"169","article-title":"Postinjection transmission scanning in myocardial 18F-FDG PET studies using both filtered backprojection and iterative reconstruction","volume":"45","author":"van der Weerdt","year":"2004","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib44","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4088\/JCP.08m04269","article-title":"Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients","volume":"70","author":"Vulink","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib45","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.npp.1301528","article-title":"Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET","volume":"33","author":"Wong","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib46","first-page":"1243","article-title":"D2-like dopamine receptor density in Tourette syndrome measured by PET","volume":"38","author":"Wong","year":"1997","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.euroneuro.2013.05.012_bib47","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1093\/brain\/awq293","article-title":"Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome","volume":"133","author":"Worbe","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2013.05.012_bib48","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archgenpsychiatry.2011.137","article-title":"Reinforcement learning and Gilles de la Tourette syndrome: dissociation of clinical phenotypes and pharmacological treatments","volume":"68","author":"Worbe","year":"2011","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13001740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13001740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T08:58:47Z","timestamp":1539507527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X13001740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0924977X13001740"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.05.012","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and ECNP.","name":"copyright","label":"Copyright"}]}}